6-K ·Filed Jun 22, 2026

BWAY

Brainsway Ltd.
BULLISH
Impact 5/10
Horizonweeks Processed3mo ago SEC0001171843-26-004211
Notable filing: 6-K
Actionable Insight ▲ Bullish

The coverage expansion strengthens the reimbursement runway for SWIFT, supporting future revenue growth. Monitor upcoming quarterly results for evidence of volume acceleration and any competitive responses from alternative TMS or neurostimulation companies.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BWAY ▼ -6.40% at T+60d
LONG call ✗ call lost -6.40% · α vs SPY -8.14% · entry $14.38 → $13.46
Entry anchored
Jun 18, 03:59 PM ET
via exchange tick
T+1d
+0.07%
call +0.07% · α +1.52%
$14.39
settled 3mo ago
T+5d
+5.49%
call +5.49% · α +5.95%
$15.17
settled 3mo ago
T+20d
+9.39%
call +9.39% · α +9.54%
$15.73
settled 2mo ago
T+60d
-6.40%
call -6.40% · α -8.14%
$13.46
settled 16d ago

Price Chart

Loading chart...

Executive Summary

BrainsWay announced expanded favorable insurance coverage for its SWIFT Accelerated Deep TMS protocol, now covering over 57 million covered lives across eight major payers and the VA. This milestone improves reimbursement access and supports future revenue growth.

Key Facts

  • Coverage expanded to over 57 million covered lives for SWIFT Accelerated Deep TMS
  • Eight major payers and the US Department of Veterans Affairs now cover or support accelerated TMS treatment approaches
  • Latest policy change adds 2 million members in South Carolina
  • Follows strong 2025 annual results: 27% revenue growth to $52.2M and net income of $7.6M (per cross-filing 20-F)

Financial Impact

Expanded coverage likely to drive incremental revenue from increased patient access and procedure volumes; no specific revenue impact quantified in filing

revenue

Risk Factors

  • Competing TMS technologies and potential market share erosion
  • Ongoing patent litigation with Magnus Medical as noted in prior annual report
  • Reimbursement changes or delays from additional payers

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-004211
Document: f6k_062126.htm0001171843-26-004211
Document: 0001171843-26-004211-index-headers.html0001171843-26-004211
Document: 0001171843-26-004211-index.html0001171843-26-004211
Document: 0001171843-26-004211.txt0001171843-26-004211
15 reports for BWAY
Performance horizon
70% Hit rate 7 of 10 directional calls best @ T+60▲ +27.55%Mar 4, 2026
Filters
Rows
Reports for BWAY — sortable, filterable
TypeNow
Sep 8, 2026
24d ago
6-K
NEUTRAL ★ 4/10
$14.16 $13.63▼ −3.74%▼ −3.08%$12.71 (−10.24%)
Aug 27, 2026
5w ago
6-K
BULLISH ★ 6/10
$14.40 $14.51▲ +0.76%▲ +0.50%$12.71 (−11.74%)
Aug 12, 2026
7w ago
6-K
BULLISH ★ 6/10
$16.47 $14.97▼ −9.11%▼ −7.14%$12.71 (−22.83%)
Aug 12, 2026
7w ago
6-K
BULLISH ★ 7/10
$16.60 $15.17▼ −8.61%▼ −8.17%$12.71 (−23.43%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$16.60 $15.17▼ −8.61%▼ −8.17%$12.71 (−23.43%)
Jul 20, 2026
10w ago
6-K
NEUTRAL ★ 4/10
$16.50 $15.97▼ −3.21%▼ −2.79%$12.71 (−22.97%)
Jul 16, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$14.84 $16.51▲ +11.25%▲ +12.92%$12.71 (−14.35%)
Jun 29, 2026
13w ago
Press Release
BULLISH ★ 6/10
$15.17 $16.02▲ +5.60%▲ +4.22%$12.71 (−16.22%)
Jun 22, 2026
14w ago
6-K
BULLISH ★ 5/10
$14.38 $15.17▲ +5.49%▲ +5.95%$12.71 (−11.61%)
May 18, 2026
19w ago
Press Release
NEUTRAL ★ 4/10
$14.88 $15.89▲ +6.79%▲ +5.17%$12.71 (−14.58%)
Showing 10 of 15

US Market Status

Market Open — Closes in 5h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access